KR20140007414A - 진단 방법 - Google Patents

진단 방법 Download PDF

Info

Publication number
KR20140007414A
KR20140007414A KR1020137022762A KR20137022762A KR20140007414A KR 20140007414 A KR20140007414 A KR 20140007414A KR 1020137022762 A KR1020137022762 A KR 1020137022762A KR 20137022762 A KR20137022762 A KR 20137022762A KR 20140007414 A KR20140007414 A KR 20140007414A
Authority
KR
South Korea
Prior art keywords
level
sample
determining
compounds
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020137022762A
Other languages
English (en)
Korean (ko)
Inventor
사이먼 디. 테일러-로빈슨
Original Assignee
임페리얼 이노베이션스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 임페리얼 이노베이션스 리미티드 filed Critical 임페리얼 이노베이션스 리미티드
Publication of KR20140007414A publication Critical patent/KR20140007414A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173845—Amine and quaternary ammonium
    • Y10T436/174614—Tertiary amine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/20—Oxygen containing
    • Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/201666—Carboxylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020137022762A 2011-01-31 2012-01-31 진단 방법 Withdrawn KR20140007414A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1101667.2A GB201101667D0 (en) 2011-01-31 2011-01-31 Diagnostic method
GB1101667.2 2011-01-31
PCT/GB2012/000100 WO2012104585A2 (en) 2011-01-31 2012-01-31 Diagnostic method

Publications (1)

Publication Number Publication Date
KR20140007414A true KR20140007414A (ko) 2014-01-17

Family

ID=43824891

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137022762A Withdrawn KR20140007414A (ko) 2011-01-31 2012-01-31 진단 방법

Country Status (9)

Country Link
US (1) US20140134751A1 (https=)
EP (1) EP2671077A2 (https=)
JP (1) JP2014505254A (https=)
KR (1) KR20140007414A (https=)
CN (1) CN103430022A (https=)
AP (1) AP2013007084A0 (https=)
AU (1) AU2012213244A1 (https=)
GB (1) GB201101667D0 (https=)
WO (1) WO2012104585A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250154643A (ko) * 2024-04-19 2025-10-29 주식회사 티엠에이오 인체내 트리메틸아민-n-옥사이드(tmao) 진단을 위한 키트 및 항체의 이용

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201307256D0 (en) * 2013-04-22 2013-05-29 Imp Innovations Ltd Diagnostic method
JP7230335B2 (ja) * 2018-04-02 2023-03-01 味の素株式会社 取得方法、算出方法、評価装置、算出装置、評価プログラム、算出プログラム、記録媒体、及び評価システム
CN111638324B (zh) * 2020-05-28 2023-08-11 长沙都正生物科技有限责任公司 一种冠心病诊断生物标记物组合及其应用
GB202102105D0 (en) * 2021-02-15 2021-03-31 Novabiotics Ltd Prognostic method
CN114414611B (zh) * 2022-01-25 2025-07-15 嘉兴大学 一种肝癌微血管侵犯鉴别模型的构建方法及肝癌微血管侵犯预测值的测试方法
WO2025008463A1 (en) 2023-07-06 2025-01-09 Numares Ag Use of a marker set for determining the risk of an individual to have hepatocellular carcinoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
CN1197973C (zh) * 2001-12-27 2005-04-20 张抗 肝癌诊断、监护及肝硬化监护试剂盒
AU2003255643A1 (en) * 2003-06-05 2005-01-21 Vincent Thomas Armbruster Measuring system for measuring at least one characteristic of a biological tissue and method for fixing a biological tissue to a measuring system of this type
US7373256B2 (en) * 2005-04-19 2008-05-13 Nicholson Jeremy K Method for the identification of molecules and biomarkers using chemical, biochemical and biological data
CN101464271A (zh) * 2007-12-19 2009-06-24 苏州艾杰生物科技有限公司 甘氨酸诊断/测定试剂盒及甘氨酸的浓度测定方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250154643A (ko) * 2024-04-19 2025-10-29 주식회사 티엠에이오 인체내 트리메틸아민-n-옥사이드(tmao) 진단을 위한 키트 및 항체의 이용

Also Published As

Publication number Publication date
CN103430022A (zh) 2013-12-04
WO2012104585A2 (en) 2012-08-09
US20140134751A1 (en) 2014-05-15
WO2012104585A3 (en) 2012-12-27
JP2014505254A (ja) 2014-02-27
EP2671077A2 (en) 2013-12-11
AU2012213244A1 (en) 2013-09-05
AP2013007084A0 (en) 2013-08-31
GB201101667D0 (en) 2011-03-16

Similar Documents

Publication Publication Date Title
Pérez-Rambla et al. Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
KR20140007414A (ko) 진단 방법
Tian et al. Wang Y
US8653006B2 (en) Metabolite biomarkers for the detection of esophageal cancer using NMR
US8321154B2 (en) Methods for detecting coronary artery disease
Bu et al. Metabolomics: a revolution for novel cancer marker identification
Eisner et al. Learning to predict cancer-associated skeletal muscle wasting from 1H-NMR profiles of urinary metabolites
CA2676091A1 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders
Sarosiek et al. Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical review
AU2011346553A1 (en) Means and method for predicting diabetes
Kostidis et al. Urinary metabolites predict prolonged duration of delayed graft function in DCD kidney transplant recipients
CN114441760A (zh) 一种用于肝癌诊断的生物标志物和试剂盒及检测方法
Dai et al. Metabolomics profile of plasma in acute diquat-poisoned patients using gas chromatography-mass spectrometry
US8563253B2 (en) Means and method for diagnosing hemolytic anemia
Firdous et al. Integrating HRMAS-NMR data and machine learning-assisted profiling of metabolite fluxes to classify low-and high-grade gliomas
US8133736B2 (en) Methods for detecting or monitoring cancer using LPE as a marker
EP4414709A1 (en) Diagnostic biomarker for cancer and use thereof
US20160091494A1 (en) Diagnostic method for hepatic cancer
US8808979B2 (en) Methods related to liver enzyme induction as a predisposition for liver toxicity and diseases or disorders associated therewith
KR102344385B1 (ko) 간암 진단용 조성물 및 이를 포함하는 키트
Natali et al. A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects.
US20240402180A1 (en) Metabolite biomarkers for differential diagnosis of pacreatic cysts
Chen et al. B-259 RNase L Deficiency Enhances Renal Self-Repair Following Nephrotoxin-induced Acute Kidney Injury via EGFR/AKT Activation and Apoptosis Inhibition
KR20250157099A (ko) 면역글로불린 a 신병증 예후 예측용 바이오마커 조성물, 이를 이용한 키트 및 이를 이용한 정보제공방법
EP4715385A1 (en) Method for testing tertiary lymphoid tissue, and kit for testing tertiary lymphoid tissue

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000